BY JESSICA VAUTOUR, SENIOR PROGRAM MANAGER, CONTINUING EDUCATION
Physicians now have access to a free, three-part video series offering the latest updates in ER+/HER2− metastatic breast cancer from leading experts who both treat patients and drive research innovation.
The series delivers practical, up-to-date knowledge on treatment strategies, sequencing decisions, biomarker testing, and the challenges of delivering personalized care in real-world settings.
Modules include:
- Therapeutic Advances — Post-CDK4/6 inhibitor options, trial data, and biomarker-driven treatment selection.
- Antibody–Drug Conjugates (ADCs) — Clinical role, biomarker integration, and sequencing strategies.
- Emerging Therapies — ER-targeting agents, PI3Kα inhibitors, and other novel approaches.
Who should watch: Oncologists, hematology/oncology physicians, PAs, and APRNs caring for patients with ER+/HER2− metastatic breast cancer.
This series is designed to help you apply evolving evidence to everyday practice and improve outcomes for your patients. Register today.
